LHX vs MDT
L3harris Technologies, Inc. and Medtronic PLC, side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | LHX | MDT |
|---|---|---|
| Revenue | $21.9B | $36.4B |
| Net income | $1.6B | $4.8B |
| Gross margin | · | 65.0% |
| Net margin | 7.3% | 13.3% |
| Return on equity | 8.2% | 9.8% |
| Diluted EPS | $8.53 | $3.73 |
| Dividend / share | $4.80 | $2.84 |
| Payout ratio | 56.2% | 75.8% |
| Free cash flow | $2.7B | $5.4B |
| Equity | $19.6B | $49.5B |
| Net debt / equity | 0.48× | 0.53× |
| Current ratio | 1.19× | 2.13× |
| Revenue CAGR 5y | 3.7% | 3.8% |
| Profit CAGR 5y | 7.5% | 5.9% |
MDT bills 1.7× the revenue of LHX, and keeps more of each dollar of revenue as profit (13.3% against 7.3%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | LHX | MDT |
|---|---|---|
| FY2025 | $21.9B | $36.4B |
| FY2024 | $21.3B | $33.5B |
| FY2023 | $19.4B | $32.4B |
| FY2022 | $17.1B | $31.2B |
| FY2021 | $17.8B | $31.7B |
| FY2020 | $18.2B | $30.1B |
| FY2019 | $12.9B | $28.9B |
| FY2018 | $6.8B | $30.6B |
| FY2017 | $6.2B | $30.0B |
| FY2016 | $5.9B | $29.7B |
Bottom line
| Fiscal year | LHX | MDT |
|---|---|---|
| FY2025 | $1.6B | $4.8B |
| FY2024 | $1.5B | $4.7B |
| FY2023 | $1.2B | $3.7B |
| FY2022 | $1.1B | $3.8B |
| FY2021 | $1.8B | $5.0B |
| FY2020 | $1.1B | $3.6B |
| FY2019 | $1.3B | $4.8B |
| FY2018 | $949.0M | $4.6B |
| FY2017 | $699.0M | $3.1B |
| FY2016 | $543.0M | $4.0B |
13 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$14,499,000,000 | MDT |
| FY2024 | −$12,212,000,000 | MDT |
| FY2023 | −$12,945,000,000 | MDT |
| FY2022 | −$14,165,000,000 | MDT |
| FY2021 | −$13,872,000,000 | MDT |
| FY2020 | −$11,923,000,000 | MDT |
| FY2019 | −$16,057,000,000 | MDT |
| FY2018 | −$23,756,000,000 | MDT |
| FY2017 | −$23,785,000,000 | MDT |
| FY2016 | −$23,813,000,000 | MDT |
| FY2014 | −$16,376,000,000 | MDT |
| FY2013 | −$11,993,000,000 | MDT |
| FY2012 | −$11,478,000,000 | MDT |
MDT has reported the higher revenue in every one of these 13 fiscal years. The gap has widened since the earliest year compared.
13 of 18 comparable fiscal years — a year missing data on either side is not counted.
13 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −6.0 pp | MDT |
| FY2024 | −6.9 pp | MDT |
| FY2023 | −5.3 pp | MDT |
| FY2022 | −5.9 pp | MDT |
| FY2021 | −5.6 pp | MDT |
| FY2020 | −6.1 pp | MDT |
| FY2019 | −6.2 pp | MDT |
| FY2018 | −1.3 pp | MDT |
| FY2017 | +1.0 pp | LHX |
| FY2016 | −4.3 pp | MDT |
| FY2014 | −4.6 pp | MDT |
| FY2013 | −7.4 pp | MDT |
| FY2012 | −18.8 pp | MDT |
The higher net margin has changed hands between LHX and MDT over this period.
13 of 18 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
LHX's net margin has been more volatile than MDT's over the 13 comparable fiscal years — 2.9 percentage points of standard deviation against 2.8.
13 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between LHX and MDT over these 13 fiscal years — LHX led in 1 and MDT in 12.
13 of 18 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
LHX's return on equity has been more volatile than MDT's over the 13 comparable fiscal years — 8.6 percentage points of standard deviation against 3.5.
13 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between LHX and MDT over these 13 fiscal years — LHX led in 6 and MDT in 7.
13 of 18 comparable fiscal years — a year missing data on either side is not counted.